TP53 and cancer: Germline pathogenic variants in TP53 classically cause Li-Fraumeni syndrome (LFS) with most carriers developing characteristic cancers, for example adrenocortical carcinoma, sarcomas and primary central nervous system (CNS) tumors [2].